| pubmed-article:3501372 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:3501372 | lifeskim:mentions | umls-concept:C0032556 | lld:lifeskim |
| pubmed-article:3501372 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:3501372 | lifeskim:mentions | umls-concept:C0444598 | lld:lifeskim |
| pubmed-article:3501372 | lifeskim:mentions | umls-concept:C0004927 | lld:lifeskim |
| pubmed-article:3501372 | lifeskim:mentions | umls-concept:C1510411 | lld:lifeskim |
| pubmed-article:3501372 | lifeskim:mentions | umls-concept:C1517806 | lld:lifeskim |
| pubmed-article:3501372 | lifeskim:mentions | umls-concept:C2323499 | lld:lifeskim |
| pubmed-article:3501372 | lifeskim:mentions | umls-concept:C0003343 | lld:lifeskim |
| pubmed-article:3501372 | lifeskim:mentions | umls-concept:C0439677 | lld:lifeskim |
| pubmed-article:3501372 | lifeskim:mentions | umls-concept:C1533691 | lld:lifeskim |
| pubmed-article:3501372 | lifeskim:mentions | umls-concept:C2348042 | lld:lifeskim |
| pubmed-article:3501372 | lifeskim:mentions | umls-concept:C0205225 | lld:lifeskim |
| pubmed-article:3501372 | pubmed:issue | 12 | lld:pubmed |
| pubmed-article:3501372 | pubmed:dateCreated | 1988-3-18 | lld:pubmed |
| pubmed-article:3501372 | pubmed:abstractText | A retrovirus encoding polyoma middle T antigen has been used to infect a murine hemopoietic cell line (FDC-P1) dependent on either granulocyte-macrophage colony-stimulating factor (GM-CSF) or multipotential colony-stimulating factor (Multi-CSF). A number of cell lines have been established on the basis of their initial ability to proliferate in the absence of added colony-stimulating factor (CSF). The transformed lines display one of three patterns of growth in vitro: those able to grow fully autonomously; those whose proliferation depends on cell density; and those displaying dependence on added CSF regardless cell density. This latter class of cells are reminiscent of the majority of primary myeloid leukemic cells. Unlike parental FDC-P1 cells, all three classes of transformed cells are leukemogenic in syngeneic mice; moreover, they produce variable amounts of GM-CSF which we believe underlies their neoplastic behavior. | lld:pubmed |
| pubmed-article:3501372 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3501372 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3501372 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3501372 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3501372 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3501372 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3501372 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3501372 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3501372 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3501372 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3501372 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3501372 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3501372 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3501372 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3501372 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3501372 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3501372 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3501372 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3501372 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3501372 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3501372 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3501372 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3501372 | pubmed:language | eng | lld:pubmed |
| pubmed-article:3501372 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3501372 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:3501372 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3501372 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3501372 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:3501372 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:3501372 | pubmed:issn | 0261-4189 | lld:pubmed |
| pubmed-article:3501372 | pubmed:author | pubmed-author:RobertsT MTM | lld:pubmed |
| pubmed-article:3501372 | pubmed:author | pubmed-author:MetcalfDD | lld:pubmed |
| pubmed-article:3501372 | pubmed:author | pubmed-author:DunnA RAR | lld:pubmed |
| pubmed-article:3501372 | pubmed:author | pubmed-author:CheringtonVV | lld:pubmed |
| pubmed-article:3501372 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:3501372 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:3501372 | pubmed:volume | 6 | lld:pubmed |
| pubmed-article:3501372 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:3501372 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:3501372 | pubmed:pagination | 3703-9 | lld:pubmed |
| pubmed-article:3501372 | pubmed:dateRevised | 2009-11-18 | lld:pubmed |
| pubmed-article:3501372 | pubmed:meshHeading | pubmed-meshheading:3501372-... | lld:pubmed |
| pubmed-article:3501372 | pubmed:meshHeading | pubmed-meshheading:3501372-... | lld:pubmed |
| pubmed-article:3501372 | pubmed:meshHeading | pubmed-meshheading:3501372-... | lld:pubmed |
| pubmed-article:3501372 | pubmed:meshHeading | pubmed-meshheading:3501372-... | lld:pubmed |
| pubmed-article:3501372 | pubmed:meshHeading | pubmed-meshheading:3501372-... | lld:pubmed |
| pubmed-article:3501372 | pubmed:meshHeading | pubmed-meshheading:3501372-... | lld:pubmed |
| pubmed-article:3501372 | pubmed:meshHeading | pubmed-meshheading:3501372-... | lld:pubmed |
| pubmed-article:3501372 | pubmed:meshHeading | pubmed-meshheading:3501372-... | lld:pubmed |
| pubmed-article:3501372 | pubmed:meshHeading | pubmed-meshheading:3501372-... | lld:pubmed |
| pubmed-article:3501372 | pubmed:meshHeading | pubmed-meshheading:3501372-... | lld:pubmed |
| pubmed-article:3501372 | pubmed:meshHeading | pubmed-meshheading:3501372-... | lld:pubmed |
| pubmed-article:3501372 | pubmed:meshHeading | pubmed-meshheading:3501372-... | lld:pubmed |
| pubmed-article:3501372 | pubmed:year | 1987 | lld:pubmed |
| pubmed-article:3501372 | pubmed:articleTitle | The in vitro behavior of hemopoietic cells transformed by polyoma middle T antigen parallels that of primary human myeloid leukemic cells. | lld:pubmed |
| pubmed-article:3501372 | pubmed:affiliation | Walter and Eliza Hall Institute of Medical Research, Royal Melbourne Hospital, Victoria, Australia. | lld:pubmed |
| pubmed-article:3501372 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:3501372 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:3501372 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3501372 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3501372 | lld:pubmed |
